Physicians and researchers at the Perelman School of Medicine at the University of Pennsylvania, the Corporal Michael J. Crescenz VA Medical Center, VA Connecticut Healthcare System, and Beth Israel Deaconess Medical Center ...
Sep 29, 2020
0
2
A Virginia Commonwealth University researcher has published preliminary but striking evidence that shows the transplantation of gut bacteria may have implications for addiction disorders.
Sep 2, 2020
0
320
The findings of an international study led by the Centenary Institute suggests that the possibility of high-risk drinkers developing alcohol-induced cirrhosis is in part related to genetic factors.
Aug 28, 2020
0
0
Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease, according to a new study from Karolinska Institutet published in the Journal of Hepatology. ...
Jul 1, 2020
0
1
Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease worldwide, affecting an estimated one-quarter of the global population. It is a progressive condition that, in worst cases, can lead to ...
Jun 30, 2020
0
105
Three hours of weekly strength training combined with protein supplements leads to both bigger and stronger muscles in patients with cirrhosis. This is shown by a new study from Aarhus University and Aarhus University Hospital.
Jun 12, 2020
0
3
Prior studies have suggested women might have higher mortality of cirrhosis of the liver than men. Women are also less likely to receive liver transplantation.
Jun 5, 2020
0
0
A new international study has found high mortality rates from COVID-19 among people with chronic liver disease and cirrhosis.
May 22, 2020
0
6
(HealthDay)—Hospitalizations for chronic liver disease (CLD) increased from 2012 to 2016, reaching a total estimated national cost of $81.1 billion, according to a study published online April 2 in JAMA Network Open.
Apr 3, 2020
0
1
(HealthDay)—Approval of Mavyret (glecaprevir and pibrentasvir) tablets has been expanded to eight-week treatment for treatment-naive patients aged 12 years and older with chronic hepatitis C virus (HCV) genotypes 1 through ...
Oct 1, 2019
0
2
